Watson Pharma Private Limited Lisinopril Export Data — India (DGFT 2022–2026)

Name: Watson Pharma Private Limited Lisinopril Export Records India — #11 Exporter, 17 Shipments, $505.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lisinopril

India Pharmaceutical Trade Intelligence

$60.4M221 Suppliers94 CountriesHS 30049071

ExportsIndia → NETHERLANDS42.6%India → UNITED STATES25.0%

ImportsCANADA → India$801.3K BULGARIA → India$278.2K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN B,V,

Watson Pharma Private Limited — Lisinopril Exporter #11 | $505.3K Trade Value | TransData Nexus | TransData Nexus

Watson Pharma Private Limited — Lisinopril Exporter Profile

Indian Pharmaceutical Exporter · #11 for Lisinopril · $505.3K export value · DGFT Verified

Watson Pharma Private Limited is the #11 Indian exporter of Lisinopril with $505.3K in export value and 17 verified shipments. Watson Pharma Private Limited holds a 0.8% market share in Lisinopril exports across 1 countries. The company exports 14 pharmaceutical products worth $63.4M across 7 therapeutic categories.

Watson Pharma Private Limited — Lisinopril Export Profile: Buyers & Destinations

Watson Pharma Private Limited Lisinopril export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Lisinopril?

Country	Value	Shipments	Share
UNITED STATES	$3.9M	78	19.6%
NIGERIA	$3.7M	99	18.6%
UNITED KINGDOM	$2.3M	95	11.5%
NETHERLANDS	$1.7M	34

Who Are the Top Buyers of Lisinopril from India?

Buyer	Country	Value	Orders
LUPIN PHARMACEUTICAL INC	UNITED STATES	$1.4M	28
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$852.4K	19
XXPINXXHARXXCEUXXCALXXINC	UNITED STATES	$850.0K	17
HAWKARY PHARMACEUTICAL COMPANY#	TURKEY	$619.4K	13
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$532.8K	67
LUPIN PHARMACEUTICALS INC	UNITED STATES	$200.0K	4
MYLAN B,V,	NETHERLANDS	$150.0K	3
GEDEON RICHTER PLC	HUNGARY	$150.0K	3
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$100.0K	2
XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX	UNITED STATES	$100.0K	2

India's Lisinopril is purchased by 450 buyers worldwide. The top buyer is LUPIN PHARMACEUTICAL INC (UNITED STATES), followed by BROWN AND BURK UK LIMITED and XXPINXXHARXXCEUXXCALXXINC.

How Does Watson Pharma Private Limited Compare to Nearest Lisinopril Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$666.6K	68	2	$9.8K
10	CIPLA LIMITED	$640.3K	64	1	$10.0K
11	WATSON PHARMA PRIVATE LIMITED ★	$505.3K	17	1	$29.7K
13	SR PHARMACEUTICAL INDUSTRIES PRIVATE LIMITED	$419.3K	10	1	$41.9K
14	SCOTT EDIL PHARMACIA LIMITED	$380.4K	21	4	$18.1K

Watson Pharma Private Limited ranks #11 among 221 Indian Lisinopril exporters. Average shipment value of $29.7K compared to the market average of $72.1K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Lisinopril Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	597	17.0%
DELHI AIR CARGO ACC (INDEL4)	514	14.6%
SAHAR AIR	509	14.5%
DELHI AIR	282	8.0%
NHAVA SHEVA SEA (INNSA1)	238	6.8%
Bombay Air	172	4.9%
HYDERABAD ICD (INSNF6)	112	3.2%
Delhi Air	110	3.1%

Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Lisinopril Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Watson Pharma. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times. These disruptions have particularly impacted time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)

Conversely, the US-China trade tensions have opened avenues for Indian exporters to strengthen their foothold in the US market. India's pharmaceutical exports to the US surged by 20.4% to approximately $10.5 billion in FY25, despite challenges such as pricing pressures and regulatory scrutiny. (economictimes.indiatimes.com) This growth underscores the potential for companies like Watson Pharma to expand their presence in the US market.

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers Watson Pharma an opportunity to increase its exports to the EU, provided it meets the stringent regulatory standards set by the European Medicines Agency (EMA). (en.wikipedia.org)

Watson Pharma Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with the number of FDA-approved manufacturing sites surpassing those in the US as of 2024. Instances of non-compliance have also decreased, reflecting improved adherence to quality standards. (business-standard.com) For Watson Pharma, maintaining and enhancing compliance with FDA, WHO GMP, and EMA standards is crucial to sustaining and expanding its export markets.

The evolving regulatory environment, including the EU's Falsified Medicines Directive, necessitates robust traceability and anti-counterfeiting measures. Watson Pharma must invest in advanced serialization and tracking systems to ensure compliance and maintain trust with international partners.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Watson Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 450+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lisinopril

Lisinopril

Watson Pharma Private Limited — Lisinopril Exporter Profile

Watson Pharma Private Limited — Lisinopril Export Profile: Buyers & Destinations

Where Does India Export Lisinopril?

Who Are the Top Buyers of Lisinopril from India?

What Is India's Total Lisinopril Export Value and How Much Does Watson Pharma Private Limited Contribute?

What Is the Average Shipment Value for Watson Pharma Private Limited's Lisinopril Exports?

How Does Watson Pharma Private Limited Compare to Other Indian Lisinopril Exporters?

Regulatory Requirements: Exporting Lisinopril to Key Markets

United States — FDA

Nigeria — NAFDAC

How Does Watson Pharma Private Limited Compare to Nearest Lisinopril Exporters?

Which Indian Ports Ship Lisinopril Exports?

What Other Cardiovascular Products Does Watson Pharma Private Limited Export?

Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Lisinopril Exports

Watson Pharma Private Limited — Regulatory Compliance & Quality Standards

About Watson Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lisinopril Export Data from Watson Pharma Private Limited

Lisinopril Stats

Company Overview

Top Products by Watson Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source